United States · FDA National Drug Code directory
Boneforce HP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43857-0591_a17db4ea-1075-4c45-8c9c-3c667443325a
- Product NDC
- 43857-0591
- Form
- LIQUID
- Composition / generic term
- Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Hydrofluoricum Acidum, Rhus Tox, Silicea, Symphytum Officinale
- Labeler
- BioActive Nutritional, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20210601
- Source listing expiry
- 20271231
Source-listed ingredients
- OYSTER SHELL CALCIUM CARBONATE, CRUDE — 30 [hp_X]/mL
- CALCIUM FLUORIDE — 30 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE — 30 [hp_X]/mL
- HEKLA LAVA — 30 [hp_X]/mL
- HYDROFLUORIC ACID — 30 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF — 30 [hp_X]/mL
- SILICON DIOXIDE — 30 [hp_X]/mL
- COMFREY ROOT — 30 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (43857-0591-1) · 43857-0591-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →